DD147360A5 - Verfahren zur herstellung von neuen 4,1-benzoxazepin-und 4,1-benzothiazepinderivaten - Google Patents
Verfahren zur herstellung von neuen 4,1-benzoxazepin-und 4,1-benzothiazepinderivaten Download PDFInfo
- Publication number
- DD147360A5 DD147360A5 DD79217162A DD21716279A DD147360A5 DD 147360 A5 DD147360 A5 DD 147360A5 DD 79217162 A DD79217162 A DD 79217162A DD 21716279 A DD21716279 A DD 21716279A DD 147360 A5 DD147360 A5 DD 147360A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- compound
- acid
- radical
- radicals
- item
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/36—Seven-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14694978A JPS5572177A (en) | 1978-11-27 | 1978-11-27 | 4,1-benzoxazepine or 4,1-benzothiazepine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD147360A5 true DD147360A5 (de) | 1981-04-01 |
Family
ID=15419209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD79217162A DD147360A5 (de) | 1978-11-27 | 1979-11-27 | Verfahren zur herstellung von neuen 4,1-benzoxazepin-und 4,1-benzothiazepinderivaten |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US4297280A (es) |
| JP (1) | JPS5572177A (es) |
| AR (1) | AR227879A1 (es) |
| AU (1) | AU533517B2 (es) |
| BE (1) | BE880282A (es) |
| CA (1) | CA1127639A (es) |
| CH (1) | CH642647A5 (es) |
| DD (1) | DD147360A5 (es) |
| DE (1) | DE2947773A1 (es) |
| DK (1) | DK500179A (es) |
| ES (4) | ES486328A0 (es) |
| FR (1) | FR2442239A1 (es) |
| GB (1) | GB2046729B (es) |
| HU (1) | HU179589B (es) |
| IT (1) | IT1165246B (es) |
| MX (1) | MX6217E (es) |
| NL (1) | NL7908596A (es) |
| NZ (1) | NZ192092A (es) |
| SE (1) | SE7909751L (es) |
| SU (2) | SU936815A3 (es) |
| ZA (1) | ZA796040B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374842A (en) * | 1980-04-18 | 1983-02-22 | Shionogi & Co., Ltd. | 4,1-Benzoxazepines and compositions |
| JPS5759893A (en) * | 1980-09-29 | 1982-04-10 | Shionogi & Co Ltd | 4,1-benzoxazepin derivative |
| CA1211437A (en) * | 1981-08-12 | 1986-09-16 | Rene Borer | Benzazepines |
| US4590187A (en) * | 1983-11-17 | 1986-05-20 | The Upjohn Company | Phospholipase A2 inhibition using 4,1-benzoxazepine-2-(3H)-ones |
| US4897392A (en) * | 1989-07-03 | 1990-01-30 | Hoechst-Roussel Pharmaceuticals, Inc. | 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines |
| US5552399A (en) * | 1994-11-02 | 1996-09-03 | Janssen Pharmaceutica N.V. | Substituted tetracyclic azepine derivatives |
| US6063921A (en) | 1997-11-20 | 2000-05-16 | Pharm-Eco Laboratories, Inc. | Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines |
| RU2266906C1 (ru) * | 2004-04-29 | 2005-12-27 | Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") | Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1090611A (en) * | 1963-05-22 | 1967-11-08 | Lepetit Spa | 4,1-benzoxazepine derivatives |
| DE1545639A1 (de) * | 1965-11-19 | 1969-08-07 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von Derivaten des 3,5-Dihydro-4,1-Benzothiazepin-2[1 H]-ons |
| BE793629A (fr) * | 1972-01-03 | 1973-07-03 | Upjohn Co | Nouveaux derives de benzodiazepines et leur preparation |
| JPS5084590A (es) * | 1973-11-28 | 1975-07-08 | ||
| US4000151A (en) * | 1974-09-11 | 1976-12-28 | The Upjohn Company | Triazolyl benzophenone compounds |
| US3933816A (en) * | 1974-09-12 | 1976-01-20 | The Upjohn Company | 3-(Substituted aminomethyl)-7-substituted-3,5-dihydro-as-triazino[4,3-a][1,5]benzodiazepines |
| US3966756A (en) * | 1975-04-07 | 1976-06-29 | American Cyanamid Company | Substituted dibenzo[b,f]tetrazolo[1,5-d][1,4]-oxazepines |
| US4246270A (en) * | 1976-05-26 | 1981-01-20 | E. I. Du Pont De Nemours And Company | 3-Fluorobenzodiazepines and compositions and uses thereof |
| US4207322A (en) * | 1975-11-04 | 1980-06-10 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler | 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines |
| US4180668A (en) * | 1977-06-08 | 1979-12-25 | The Upjohn Company | Piperidino-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
| JPS54119499A (en) * | 1978-03-09 | 1979-09-17 | Shionogi & Co Ltd | Triazolobenzodiazepin derivative |
-
1978
- 1978-11-27 JP JP14694978A patent/JPS5572177A/ja active Granted
-
1979
- 1979-11-02 CA CA339,060A patent/CA1127639A/en not_active Expired
- 1979-11-06 US US06/091,814 patent/US4297280A/en not_active Expired - Lifetime
- 1979-11-09 ZA ZA00796040A patent/ZA796040B/xx unknown
- 1979-11-12 NZ NZ192092A patent/NZ192092A/en unknown
- 1979-11-20 AU AU52993/79A patent/AU533517B2/en not_active Ceased
- 1979-11-22 CH CH1042379A patent/CH642647A5/de not_active IP Right Cessation
- 1979-11-23 DK DK500179A patent/DK500179A/da not_active Application Discontinuation
- 1979-11-26 FR FR7929096A patent/FR2442239A1/fr active Granted
- 1979-11-26 HU HU79SI1731A patent/HU179589B/hu unknown
- 1979-11-26 IT IT7969279A patent/IT1165246B/it active
- 1979-11-26 ES ES486328A patent/ES486328A0/es active Granted
- 1979-11-26 SE SE7909751A patent/SE7909751L/xx not_active Application Discontinuation
- 1979-11-27 DE DE19792947773 patent/DE2947773A1/de not_active Withdrawn
- 1979-11-27 BE BE0/198307A patent/BE880282A/fr not_active IP Right Cessation
- 1979-11-27 SU SU792847003A patent/SU936815A3/ru active
- 1979-11-27 AR AR279045A patent/AR227879A1/es active
- 1979-11-27 GB GB7940898A patent/GB2046729B/en not_active Expired
- 1979-11-27 NL NL7908596A patent/NL7908596A/xx not_active Application Discontinuation
- 1979-11-27 DD DD79217162A patent/DD147360A5/de unknown
- 1979-11-27 MX MX798501U patent/MX6217E/es unknown
-
1980
- 1980-07-28 ES ES493761A patent/ES493761A0/es active Granted
- 1980-07-28 ES ES493759A patent/ES8106729A1/es not_active Expired
- 1980-07-28 ES ES493760A patent/ES8106730A1/es not_active Expired
- 1980-12-04 SU SU803211176A patent/SU1005660A3/ru active
-
1981
- 1981-06-23 US US06/276,632 patent/US4341704A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES493760A0 (es) | 1981-08-01 |
| FR2442239A1 (fr) | 1980-06-20 |
| ES8106731A1 (es) | 1981-08-01 |
| ZA796040B (en) | 1980-10-29 |
| ES493759A0 (es) | 1981-08-01 |
| FR2442239B1 (es) | 1983-07-01 |
| IT1165246B (it) | 1987-04-22 |
| DK500179A (da) | 1980-05-28 |
| GB2046729B (en) | 1983-01-26 |
| US4341704A (en) | 1982-07-27 |
| NL7908596A (nl) | 1980-05-29 |
| SE7909751L (sv) | 1980-05-28 |
| HU179589B (en) | 1982-11-29 |
| IT7969279A0 (it) | 1979-11-26 |
| AR227879A1 (es) | 1982-12-30 |
| CH642647A5 (de) | 1984-04-30 |
| JPS6231719B2 (es) | 1987-07-09 |
| AU5299379A (en) | 1980-05-29 |
| JPS5572177A (en) | 1980-05-30 |
| SU1005660A3 (ru) | 1983-03-15 |
| ES8102106A1 (es) | 1980-12-16 |
| CA1127639A (en) | 1982-07-13 |
| MX6217E (es) | 1984-12-21 |
| DE2947773A1 (de) | 1980-06-04 |
| ES486328A0 (es) | 1980-12-16 |
| ES493761A0 (es) | 1981-08-01 |
| GB2046729A (en) | 1980-11-19 |
| ES8106730A1 (es) | 1981-08-01 |
| BE880282A (fr) | 1980-03-17 |
| SU936815A3 (ru) | 1982-06-15 |
| US4297280A (en) | 1981-10-27 |
| AU533517B2 (en) | 1983-12-01 |
| NZ192092A (en) | 1984-07-31 |
| ES8106729A1 (es) | 1981-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0150040B1 (de) | Imidazodiazepin-Derivate | |
| EP0027214A1 (de) | Imidazodiazepin-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, diese enthaltende Arzneimittel und deren therapeutische Verwendung | |
| DE2940483A1 (de) | 5h-2,3-benzodiazepinderivate, verfahren zur herstellung derselben und diese enthaltende arzneimittel | |
| DE2609486C2 (es) | ||
| DD147360A5 (de) | Verfahren zur herstellung von neuen 4,1-benzoxazepin-und 4,1-benzothiazepinderivaten | |
| DE2813549A1 (de) | Imidazodiazepinderivate, verfahren zu ihrer herstellung und arzneimittel | |
| DE1770756A1 (de) | Piperazinderivate und Verfahren zu deren Herstellung | |
| DE1695132A1 (de) | Verfahren zur Herstellung von heterocyclischen Verbindungen | |
| DE3115552A1 (de) | 4,1-benzoxazepine und diese verbindungen enthaltende arzneimittel | |
| EP0057428B1 (de) | Tricyclische Pyrrole, Verfahren zu ihrer Herstellung, ihre Anwendung sowie sie enthaltende Arzneimittel | |
| EP0072029B1 (de) | Triazolobenzazepine, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE2712309A1 (de) | As-triazinobenzodiazepin-1-one, benzodiazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
| EP0135770A2 (de) | Imidazobenzodiazepinderivate, Verfahren zu deren Herstellung und Arzneimittel enthaltend diese Verbindungen | |
| DE1695211A1 (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| DE3014011A1 (de) | Benzo-as-triazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| CH615435A5 (es) | ||
| DE2141443C3 (de) | U-Dihydro-S-phenyl^H-M-benzodiazepin-2-one, ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel | |
| AT295539B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und deren N-5-Oxyden | |
| DE2155403C3 (de) | 1,3-Dihydro-5-phenyl-2H-thienoeckige Klammer auf 2,3-e eckige Klammer zu -1,4-diazepin-2-on-derivate | |
| DE2410030C3 (de) | 8-Brom-6-phenyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| AT276400B (de) | Verfahren zur Herstellung von neuen Benzodiazepin-Derivaten und von deren Säureadditionssalzen und quaternären Salzen | |
| DE3331858A1 (de) | Neue 11-piperazinyl-5h-imidazo(2,1-c)(1,4)benzodiazepine, verfahren zu ihrer herstellung und zwischenprodukte und erstere enthaltende arzneimittel | |
| AT395154B (de) | Verfahren zur herstellung von neuen imidazo(1,5-a)(1,4)diazepinverbindungen | |
| DE69612413T2 (de) | 1-(Hetero)Arylvinyl-5H-2,3-benzodiazepinderivative verwendbar zur Behandlung von Erkrankungen des Zentralnervensystems, sowie Benzopyrylium Intermediate zu ihrer Herstellung | |
| AT395155B (de) | Verfahren zur herstellung von neuen imidazo(1,5-a)(1,4)diazepinverbindungen |